ClinicalTrials.gg
SuspendedNCT07711340Updated Sep 28, 2026

Diurnal Strength Variation

An interventional study of Time-driven dosing in Healthy Adult and Exercise, sponsored by Stanford University. Suspended at 1 site in United States. Open to participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-28.

Sponsored by Stanford University · Not applicable, Interventional, and Basic science

How we know

Why this study was suspended
no personnel to current run this study
Updated Sep 28, 2026Now SuspendedPrimary completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 35 studies in Motor Activity by Stanford University — 7 open to participants now, 8 under way, none of them phase 3. Motor Activity · Stanford University.

Planned enrollment
31st of 33
20 · median 79
Started
2026
with 2 others
No phase
28 of 35
7 open now
Registered
35th of 35
by date

Among the 35 studies in Motor Activity by Stanford University, this one is the 31st largest by planned enrollment of the 33 interventional ones that give a count, is one of 3 that started in 2026, is one of 28 with no phase, and was the 35th registered.

Motor Activity

9,827 studies on the registry are indexed under Motor Activity; 1,911 are open to participants now.

Browse Motor Activity studies →

Open to participants now

7 of the 35 studies in Motor Activity by Stanford University are open now, in 1 country. Recruiting first, the newest first:

2 more — sign in →

By country, each count listing its studies:

All 7 open studies →

Where they have run

Who these studies take

Of the 1,207 Motor Activity studies recruiting now, 524 (43%) set no upper age limit and 538 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.

This study: 18 Years to 25 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 35 studies in Motor Activity by Stanford University, or all of them as a file.
02

Study summary

Healthy individuals will be tested at different times of day to determine whether exercise at a non-expected time results in poorer performance.

03

Conditions studied

  • Healthy Adult
  • Exercise

Browse trials for

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy
  • 18-25 years old
  • Lower body exercise three or more times per week, all at the same time of day (within 2 hour window)
  • Regular meal times (±1 hour window)
  • Regular sleep times (±1 hour window)

Exclusion criteria

Exclusion Criteria:

  • Active or uncontrolled mental or physical health issues
  • Current musculoskeletal injury
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
20 participants (estimated)

Study arms

  • No intervention
    Regular Exercise

    Exercise at the usual time

  • Experimental
    Early Exercise

    Exercise three hours earlier than usual

    Behavioral: Time-driven dosing

  • Experimental
    Exercise Late

    Exercise three hours later than usual

    Behavioral: Time-driven dosing

Interventions

  • BehavioralTime-driven dosing

    Three hours earlier or later than usual exercise

06

What researchers measure

Primary outcomes

  1. Isometric quadriceps strength

    isometric quadriceps strength as determined during dynamometer testing

    Time frame: 15 minutes

Secondary outcomes

  1. Isometric hamstring strength

    Hamstring strength as determined during dynamometer testing

    Time frame: 15 minutes

  2. Isokinetic hamstring/quad strength

    Hamstring/quad strength as determined during dynamometer testing

    Time frame: 15 minutes

07

Study locations

1 site
  • Stanford University
    Stanford, California 94305, United States
08

References and documents

Individual participant data

Plan to share: Yes — Deidentified outcome data from muscle testing will be shared on Dryad.

Access criteria: open access

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Aug 2026 (actual). Primary completion is estimated for Sep 2027, 13 months after the start.

Since we started tracking on Sep 25, 2026, the dates moved once, on Sep 28, 2026: primary completion Sep 2026 → Sep 2027 and completion Dec 2026 → Dec 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jul 14, 2026
First posted
Jul 17, 2026
StartActual
Aug 1, 2026
Primary completionEst.
Sep 30, 2027was Sep 2026
CompletionEst.
Dec 31, 2027was Dec 2026
Last update
Sep 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Suspended no personnel to current run this study
changed Sep 28, 2026
Primary completion
Sep 30, 2026→Sep 30, 2027
Sep 28, 2026
Study completion
Dec 31, 2026→Dec 31, 2027
Sep 28, 2026
Show all 1 update
  1. Sep 28, 2026
    Not yet recruiting→Suspended
    Why stopped no personnel to current run this study
    Primary completion Sep 30, 2026→Sep 30, 2027
    Study completion Dec 31, 2026→Dec 31, 2027
    + 2 other changes: verification date and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07711340
Responsible party
Jamie Zeitzer (Professor, Stanford University) — Principal investigator
First posted
Jul 17, 2026
Start date
Aug 1, 2026
Primary completion
Sep 30, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Sep 28, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is suspended, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion